Vaxinano is a clinical-stage biotechnology company, developing a new generation of nasally administered vaccines that are more efficient and faster to deploy to combat infectious diseases and new pandemics.
The vaccine is based on STELLAR-NP nanoparticles that confer highly stable, adjuvant-free solution for an effective and long-lasting response tot protect against the most difficult pathogens, such as parasites, viruses or bacteria...
Company Details
- Employees
- 14
- Address
- Loos, Hauts-De-France
- co****@****ano.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- vaxinano.com
- HQ
- Loos, Hauts-de-France
Vaxinano Questions
Vaxinano's website is vaxinano.com
Vaxinano's LinkedIn profile is https://fr.linkedin.com/company/vaxinano
Vaxinano has
14 employees.
View email and phone details for 14
employees at Vaxinano.
Vaxinano's industry is
Biotechnology Research
Vaxinano's top competitors are
Energic, Le Challenge Environnemental,
Kamea Labs,
Aliri Bioanalysis,
Starfish Bioscience,
La Consignerie,
Beyond Aero,
Hubcycle,
Hemerion Therapeutics,
Filigran,
Netzero.
Vaxinano's support email address is contact@vaxinano.com
Vaxinano's categories are Biotechnology Research
